St. Anna Children's Cancer Research Institute (CCRI)
Wolfgang Paster has a wide range of work experience in the field of research and laboratory management. Wolfgang is currently employed at St. Anna Children's Cancer Research Institute (CCRI) where they hold multiple roles including Lab Head of Clinical Cell Biology and FACS Core Unit, Head of Quality Control Laboratory, and Qualified Person. Prior to their current position, they served as the Deputy Lab Head of Clinical Cell Biology and Deputy Head of Quality Control Laboratory at CCRI.
Before joining CCRI, Wolfgang worked as a Postdoctoral Research Associate at the Medical University of Vienna from 2015 to 2017. Wolfgang also gained valuable experience at the University of Oxford, where they served as a Postdoctoral Fellow from 2008 to 2014 and at the Medical University of Vienna as a Postdoctoral Fellow from 2006 to 2008. Their early career at Boehringer Ingelheim started as a Master Student in 2001.
Throughout their career, Wolfgang Paster has showcased their expertise in research and laboratory management, making significant contributions to the field of cancer research.
Wolfgang Paster's education history begins in 1996 when they enrolled in the University of Vienna to pursue a Master's degree in Microbiology, General. Wolfgang successfully completed this program in 2002. Following this, Paster joined the Medical University of Vienna in 2002 and pursued a Doctor of medical sciences degree with a specialization in Cellular Signalling. Wolfgang completed this program in 2006. In 2018, Paster returned to the University of Vienna to undertake a Universitätslehrgang Pharmazeutisches Qualitätsmanagement, which was completed that same year.
This person is not in any offices
St. Anna Children's Cancer Research Institute (CCRI)
The St. Anna Children's Cancer Research Institute (St Anna CCRI), located in the center of Vienna, the world's most livable city and one of Europe's most important places for biomedical research and life sciences, is an internationally renowned multidisciplinary research institution with the aim to develop and optimize diagnostic, prognostic, and therapeutic strategies for the treatment of children and adolescents with cancer. To achieve this goal we combine basic research with translational and clinical research and focus on the specific characteristics of childhood tumor diseases in order to provide young patients with the best possible and most innovative therapies. Dedicated research groups in the fields of tumor genomics and epigenomics, immunology, molecular biology, cell biology, bioinformatics and clinical research are working together to harmonize scientific findings with the clinical needs of physicians to ultimately improve the wellbeing of our patients. Through close cooperation between clinic and research, the CCRI provides an ideal environment for cutting-edge research and its translation into clinical practice. To achieve our ultimate goal of advancing the well-being of patients, the CCRI constantly pushes scientific boundaries and strongly promotes close collaboration and exchange with external institutions like the Medical University of Vienna, CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, the Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA) and the Institute of Molecular Pathology (IMP).